-
Novel Meta-Analysis Shows VATS Improves Overall Survival in Early-Stage Lung Cancer
Dr. Jacie Jiaqi Law shared results from a first-ever meta-analysis demonstrating that VATS reduces mortality risk without compromising disease-free survival.
More Recent News
-
Lost in Translation: Survey Reveals Critical Communication Gaps in Lung Cancer Care
Complex information and poor communication were identified as major obstacles to meaningful participation in decision-making, according to data presented by patient advocate Debra Montague.
-
EA5181 Confirms Durvalumab After CRT is SOC for Unresectable Stage III NSCLC
Dr. John Varlotto highlighted that the survival curves were ‘superimposable,’ showing no differences in median OS or PFS outcomes.